Skip to main content
. 2022 Nov 6;3(12):100428. doi: 10.1016/j.jtocrr.2022.100428

Figure 4.

Figure 4

Timeline of the patient’s treatment course spanning from the initial diagnosis to the most recent follow-up at time of the report. PD-L1, programmed death-ligand 1; PemCBev, carboplatin, pemetrexed, bevacizumab; QD, twice daily; RT, radiotherapy.